Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
A A Pract ; 18(6): e01792, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38828972

ABSTRACT

Awake combined spinal caudal anesthesia has been used as an anesthetic technique for longer-duration infraumbilical surgeries in infants. Literature on the safety and feasibility of this technique is limited. We share our experience with 27 infants undergoing longer-duration urologic surgery using awake combined spinal and caudal anesthesia without the use of systemic sedatives or inhalational agents. We describe our technique, safety considerations, and details surrounding the optimal timing of caudal catheter activation for prolongation of surgical anesthesia.


Subject(s)
Anesthesia, Caudal , Anesthesia, Spinal , Urologic Surgical Procedures , Humans , Anesthesia, Caudal/methods , Infant , Urologic Surgical Procedures/methods , Anesthesia, Spinal/methods , Male , Female , Infant, Newborn , Wakefulness
2.
Telecomm Policy ; 47(4): 102499, 2023 May.
Article in English | MEDLINE | ID: mdl-36685614

ABSTRACT

Having adequate access to the internet at home enhances quality-of-life for households and facilitates economic and social opportunities. Despite increased investment in response to the COVID-19 pandemic, millions of households in the rural United States still lack adequate access to high-speed internet. In this study, we evaluate a wireless broadband network deployed in Turney, a small, underserved rural community in northwest Missouri. In addition to collecting survey data before and after this internet intervention, we collected pre-treatment and post-treatment survey data from comparison communities to serve as a control group. Due to technical constraints, some of Turney's interested participants could not connect to the network, creating an additional comparison group. These comparisons suggest two primary findings, (1) changes in using the internet for employment, education, and health could not be directly attributed to the internet intervention, and (2) the internet intervention was associated with benefits stemming from the ability to use multiple devices at once. This study has implications for the design of future broadband evaluation studies, particularly those examining underserved rather than unserved communities. Recommendations for identifying appropriate outcome variables, executing recruitment strategies, and selecting the timing of surveys are made.

3.
Telecomm Policy ; 46(7): 102310, 2022 Aug.
Article in English | MEDLINE | ID: mdl-35132293

ABSTRACT

Amidst COVID-19-related stay-at-home orders, the economy moved largely online and broadband internet became more important than ever. This paper explores the relationship between broadband and employment rates during April and May 2020 in rural U.S. counties. We use two broadband dimensions: infrastructure availability rates and household adoption rates. We use a two-stage least squares approach to address endogeneity and control for socioeconomic, demographic, and pandemic-related factors. Results show broadband availability and wired broadband adoption both had significant, positive impacts on the employment rate. Our findings suggest both broadband adoption and availability may be associated with economic benefits in rural America.

4.
Postgrad Med ; 133(1): 20-27, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32921198

ABSTRACT

While COVID-19 has primarily been characterized by the respiratory impact of viral pneumonia, it affects every organ system and carries a high consequent risk of death in critically ill patients. Higher sequential organ failure assessment (SOFA) scores have been associated with increased mortality in patients critically ill patients with COVID-19. It is important that clinicians managing critically ill COVID-19 patients be aware of the multisystem impact of the disease so that care can be focused on the prevention of end-organ injuries to potentially improve clinical outcomes. We review the multisystem complications of COVID-19 and associated treatment strategies to improve the care of critically ill COVID-19 patients.


Subject(s)
COVID-19/physiopathology , COVID-19/mortality , Cardiovascular Diseases/physiopathology , Critical Illness , Cytokines/biosynthesis , Endocrine System Diseases/physiopathology , Gastrointestinal Diseases/physiopathology , Hematologic Diseases/physiopathology , Humans , Kidney Diseases/physiopathology , Musculoskeletal Diseases/physiopathology , Nervous System Diseases/physiopathology , Obesity/physiopathology , Organ Dysfunction Scores , Respiratory Tract Diseases/physiopathology , Risk Factors , SARS-CoV-2 , Skin Diseases/physiopathology , Systemic Inflammatory Response Syndrome/physiopathology
5.
Crit Care Explor ; 2(6): e0146, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32696009

ABSTRACT

The global spread of coronavirus disease 2019 has accelerated the adoption of technologies that facilitate patient care while reducing viral spread. We illustrate a proof of concept application of teleguidance to ultrasound-guided bedside procedures as an example of an innovative solution that has been used at our institution to maximize patient and provider safety.

6.
Neuron ; 98(1): 90-108.e5, 2018 04 04.
Article in English | MEDLINE | ID: mdl-29576387

ABSTRACT

Cellular interactions between delta and mu opioid receptors (DORs and MORs), including heteromerization, are thought to regulate opioid analgesia. However, the identity of the nociceptive neurons in which such interactions could occur in vivo remains elusive. Here we show that DOR-MOR co-expression is limited to small populations of excitatory interneurons and projection neurons in the spinal cord dorsal horn and unexpectedly predominates in ventral horn motor circuits. Similarly, DOR-MOR co-expression is rare in parabrachial, amygdalar, and cortical brain regions processing nociceptive information. We further demonstrate that in the discrete DOR-MOR co-expressing nociceptive neurons, the two receptors internalize and function independently. Finally, conditional knockout experiments revealed that DORs selectively regulate mechanical pain by controlling the excitability of somatostatin-positive dorsal horn interneurons. Collectively, our results illuminate the functional organization of DORs and MORs in CNS pain circuits and reappraise the importance of DOR-MOR cellular interactions for developing novel opioid analgesics.


Subject(s)
Anterior Horn Cells/metabolism , Nerve Net/metabolism , Pain/metabolism , Posterior Horn Cells/metabolism , Receptors, Opioid, delta/biosynthesis , Receptors, Opioid, mu/biosynthesis , Animals , Anterior Horn Cells/chemistry , Anterior Horn Cells/pathology , Central Nervous System/chemistry , Central Nervous System/metabolism , Central Nervous System/pathology , Male , Mice, Inbred C57BL , Mice, Knockout , Nerve Net/chemistry , Nerve Net/pathology , Pain/pathology , Pain Measurement/methods , Posterior Horn Cells/chemistry , Posterior Horn Cells/pathology , Receptors, Opioid, delta/genetics , Receptors, Opioid, mu/genetics
7.
J Pain Res ; 10: 973-977, 2017.
Article in English | MEDLINE | ID: mdl-28490900

ABSTRACT

A 41-year-old woman presented with burning and erythema in her extremities triggered by warmth and activity, which was relieved by applying ice. Extensive workup was consistent with adult-onset primary erythromelalgia (EM). Several pharmacological treatments were tried including local anesthetics, capsaicin, ziconotide, and dantrolene, all providing 24-48 hours of relief followed by symptom flare. Interventional therapies, including peripheral and sympathetic ganglion blocks, also failed. Thus far, clonidine and ketamine have been the only effective agents for our patient. Genetic testing was negative for an EM-associated mutation in the SCN9A gene, encoding the NaV1.7 sodium channel, suggesting a mutation in an alternate gene.

8.
Neuron ; 93(4): 822-839.e6, 2017 Feb 22.
Article in English | MEDLINE | ID: mdl-28162807

ABSTRACT

Pain thresholds are, in part, set as a function of emotional and internal states by descending modulation of nociceptive transmission in the spinal cord. Neurons of the rostral ventromedial medulla (RVM) are thought to critically contribute to this process; however, the neural circuits and synaptic mechanisms by which distinct populations of RVM neurons facilitate or diminish pain remain elusive. Here we used in vivo opto/chemogenetic manipulations and trans-synaptic tracing of genetically identified dorsal horn and RVM neurons to uncover an RVM-spinal cord-primary afferent circuit controlling pain thresholds. Unexpectedly, we found that RVM GABAergic neurons facilitate mechanical pain by inhibiting dorsal horn enkephalinergic/GABAergic interneurons. We further demonstrate that these interneurons gate sensory inputs and control pain through temporally coordinated enkephalin- and GABA-mediated presynaptic inhibition of somatosensory neurons. Our results uncover a descending disynaptic inhibitory circuit that facilitates mechanical pain, is engaged during stress, and could be targeted to establish higher pain thresholds. VIDEO ABSTRACT.


Subject(s)
Enkephalins/metabolism , GABAergic Neurons/metabolism , Interneurons/metabolism , Neural Pathways/physiology , Pain/physiopathology , Spinal Cord/metabolism , Animals , Brain Stem/metabolism , Brain Stem/physiopathology , Medulla Oblongata/metabolism , Mice, Transgenic , Spinal Cord Dorsal Horn/metabolism , Spinal Cord Dorsal Horn/physiopathology
9.
Nat Med ; 23(2): 164-173, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28092666

ABSTRACT

Opioid pain medications have detrimental side effects including analgesic tolerance and opioid-induced hyperalgesia (OIH). Tolerance and OIH counteract opioid analgesia and drive dose escalation. The cell types and receptors on which opioids act to initiate these maladaptive processes remain disputed, which has prevented the development of therapies to maximize and sustain opioid analgesic efficacy. We found that µ opioid receptors (MORs) expressed by primary afferent nociceptors initiate tolerance and OIH development. RNA sequencing and histological analysis revealed that MORs are expressed by nociceptors, but not by spinal microglia. Deletion of MORs specifically in nociceptors eliminated morphine tolerance, OIH and pronociceptive synaptic long-term potentiation without altering antinociception. Furthermore, we found that co-administration of methylnaltrexone bromide, a peripherally restricted MOR antagonist, was sufficient to abrogate morphine tolerance and OIH without diminishing antinociception in perioperative and chronic pain models. Collectively, our data support the idea that opioid agonists can be combined with peripheral MOR antagonists to limit analgesic tolerance and OIH.


Subject(s)
Analgesics, Opioid/pharmacology , Drug Tolerance/genetics , Hyperalgesia/genetics , Microglia/metabolism , Morphine/pharmacology , Nociceptors/metabolism , Receptors, Opioid, mu/genetics , Analgesia , Animals , Chronic Pain , Disease Models, Animal , Gene Deletion , Hyperalgesia/chemically induced , Long-Term Potentiation/drug effects , Long-Term Potentiation/genetics , Mice , Mice, Knockout , Naltrexone/analogs & derivatives , Naltrexone/pharmacology , Nociception/drug effects , Pain, Postoperative , Quaternary Ammonium Compounds/pharmacology , Receptors, Opioid, mu/antagonists & inhibitors , Signal Transduction , Spinal Cord/cytology , Spinal Cord/metabolism
10.
Neuron ; 84(1): 123-136, 2014 Oct 01.
Article in English | MEDLINE | ID: mdl-25242222

ABSTRACT

One feature of neuropathic pain is a reduced GABAergic inhibitory function. Nociceptors have been suggested to play a key role in this process. However, the mechanisms behind nociceptor-mediated modulation of GABA signaling remain to be elucidated. Here we describe the identification of GINIP, a Gαi-interacting protein expressed in two distinct subsets of nonpeptidergic nociceptors. GINIP null mice develop a selective and prolonged mechanical hypersensitivity in models of inflammation and neuropathy. GINIP null mice show impaired responsiveness to GABAB, but not to delta or mu opioid receptor agonist-mediated analgesia specifically in the spared nerve injury (SNI) model. Consistently, GINIP-deficient dorsal root ganglia neurons had lower baclofen-evoked inhibition of high-voltage-activated calcium channels and a defective presynaptic inhibition of lamina IIi interneurons. These results further support the role of unmyelinated C fibers in injury-induced modulation of spinal GABAergic inhibition and identify GINIP as a key modulator of peripherally evoked GABAB-receptors signaling.


Subject(s)
Analgesia/methods , GTP-Binding Protein alpha Subunits, Gi-Go/physiology , Receptors, GABA-B/physiology , Amino Acid Sequence , Animals , Enkephalin, Ala(2)-MePhe(4)-Gly(5)-/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Ganglia, Spinal/drug effects , Ganglia, Spinal/physiology , HEK293 Cells , Humans , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Molecular Sequence Data , Pain Measurement/drug effects , Pain Measurement/methods , Rats
11.
BMC Genomics ; 15: 345, 2014 May 08.
Article in English | MEDLINE | ID: mdl-24884839

ABSTRACT

BACKGROUND: Opioids are the cornerstone of treatment for moderate to severe pain, but chronic use leads to maladaptations that include: tolerance, dependence and opioid-induced hyperalgesia (OIH). These responses limit the utility of opioids, as well as our ability to control chronic pain. Despite decades of research, we have no therapies or proven strategies to overcome this problem. However, murine haplotype based computational genetic mapping and a SNP data base generated from analysis of whole-genome sequence data (whole-genome HBCGM), provides a hypothesis-free method for discovering novel genes affecting opioid maladaptive responses. RESULTS: Whole genome-HBCGM was used to analyze phenotypic data on morphine-induced tolerance, dependence and hyperalgesia obtained from 23 inbred strains. The robustness of the genetic mapping results was analyzed using strain subsets. In addition, the results of analyzing all of the opioid-related traits together were examined. To characterize the functional role of the leading candidate gene, we analyzed transgenic animals, mRNA and protein expression in behaviorally divergent mouse strains, and immunohistochemistry in spinal cord tissue. Our mapping procedure identified the allelic pattern within the netrin-1 receptor gene (Dcc) as most robustly associated with OIH, and it was also strongly associated with the combination of the other maladaptive opioid traits analyzed. Adult mice heterozygous for the Dcc gene had significantly less tendency to develop OIH, become tolerant or show evidence of dependence after chronic exposure to morphine. The difference in opiate responses was shown not to be due to basal or morphine-stimulated differences in the level of Dcc expression in spinal cord tissue, and was not associated with nociceptive neurochemical or anatomical alterations in the spinal cord or dorsal root ganglia in adult animals. CONCLUSIONS: Whole-genome HBCGM is a powerful tool for identifying genes affecting biomedical traits such as opioid maladaptations. We demonstrate that Dcc affects tolerance, dependence and OIH after chronic opioid exposure, though not through simple differences in expression in the adult spinal cord.


Subject(s)
Hyperalgesia/chemically induced , Morphine/administration & dosage , Receptors, Cell Surface/genetics , Animals , Behavior, Animal/drug effects , Chromosome Mapping , Databases, Factual , Drug Tolerance , Genome , Haplotypes , Heterozygote , Hyperalgesia/genetics , Hyperalgesia/pathology , Injections, Subcutaneous , Mice , Mice, Inbred C57BL , Morphine/adverse effects , Morphine/pharmacology , Netrin Receptors , Proteins/metabolism , RNA/metabolism , Receptors, Cell Surface/metabolism , Spinal Cord/drug effects , Spinal Cord/metabolism
12.
Proc Natl Acad Sci U S A ; 107(51): 22296-301, 2010 Dec 21.
Article in English | MEDLINE | ID: mdl-21135246

ABSTRACT

Dorsal root ganglia (DRG) neurons, including the nociceptors that detect painful thermal, mechanical, and chemical stimuli, transmit information to spinal cord neurons via glutamatergic and peptidergic neurotransmitters. However, the specific contribution of glutamate to pain generated by distinct sensory modalities or injuries is not known. Here we generated mice in which the vesicular glutamate transporter 2 (VGLUT2) is ablated selectively from DRG neurons. We report that conditional knockout (cKO) of the Slc17a6 gene encoding VGLUT2 from the great majority of nociceptors profoundly decreased VGLUT2 mRNA and protein in these neurons, and reduced firing of lamina I spinal cord neurons in response to noxious heat and mechanical stimulation. In behavioral assays, cKO mice showed decreased responsiveness to acute noxious heat, mechanical, and chemical (capsaicin) stimuli, but responded normally to cold stimulation and in the formalin test. Strikingly, although tissue injury-induced heat hyperalgesia was lost in the cKO mice, mechanical hypersensitivity developed normally. In a model of nerve injury-induced neuropathic pain, the magnitude of heat hypersensitivity was diminished in cKO mice, but both the mechanical allodynia and the microgliosis generated by nerve injury were intact. These findings suggest that VGLUT2 expression in nociceptors is essential for normal perception of acute pain and heat hyperalgesia, and that heat and mechanical hypersensitivity induced by peripheral injury rely on distinct (VGLUT2 dependent and VGLUT2 independent, respectively) primary afferent mechanisms and pathways.


Subject(s)
Ganglia, Spinal/metabolism , Gene Expression Regulation , Hot Temperature , Hyperalgesia/metabolism , Nociceptors/metabolism , Pain/metabolism , Vesicular Glutamate Transport Protein 2/biosynthesis , Animals , Behavior, Animal/drug effects , Capsaicin/pharmacology , Cold Temperature , Fixatives/pharmacology , Formaldehyde/pharmacology , Hyperalgesia/genetics , Mice , Mice, Knockout , Pain/genetics , Sensory System Agents/pharmacology , Vesicular Glutamate Transport Protein 2/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...